Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_573f6d86307f10048cc0016ea5715518 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
filingDate |
2007-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b24ae57898c07fe83a86fabaede86c4c |
publicationDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008188541-A1 |
titleOfInvention |
In vivo assessment of toxicity and pharmacokinetics of methylglyoxal |
abstract |
A pharmaceutical composition and treatment method to reduce the proliferation of cancerous or tumor cells, in which the combined active agents are methylglyoxal, ascorbic acid, creatine and melatonin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198896-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163796-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011118327-A1 |
priorityDate |
2006-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |